Prostate Cancer News
CPRIT awards $13M for prevention, research, recruitment Aug 18, 2017 Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
Serendipitous finding leads scientists to propose new mechanism to explain benign prostatic hyperplasia Sep 1, 2016 Researchers suggest strategies to improve the response to androgen-targeting therapies, which are usually used to treat prostate cancer and benign prostatic hyperplasia.
President Obama names Margaret Spitz to National Cancer Advisory Board Aug 12, 2016 Renowned expert in molecular epidemiology Dr. Margaret Spitz to advocate for cancer prevention and health disparities on the National Cancer Advisory Board.
Mouse model shows that Notch activation can drive metastatic prostate cancer Jun 13, 2016 Researchers find that in mouse models, Notch signaling promotes the ability of tumors to spread to other organs.
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapies May 19, 2016 Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.
Electronic trigger reduces delays in evaluation for cancer diagnosis Aug 24, 2015 Electronic triggers designed to search for key data were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
Baylor’s Dan L Duncan Cancer Center receives highest National Cancer Institute designation – Comprehensive status Jul 30, 2015 The National Cancer Institute has awarded the Dan L Duncan Cancer Center at Baylor College of Medicine the prestigious designation of a Comprehensive Cancer Center.
Baylor College of Medicine's Duncan Cancer Center receives additional $15.9 million in state cancer funding May 29, 2015 Researchers in the NCI-designated Dan L Duncan Cancer Center at Baylor College of Medicine have received $15.9 million from the Cancer Prevention and Research Institute of Texas for two new large grants focused on liver cancer and prostate cancer.
Baylor College of Medicine receives an additional $11 million in state cancer funding Feb 23, 2015 Baylor researchers receive nine new grants totaling $11.3 million in the latest round of funding awarded by the Cancer Prevention and Research Institute of Texas.
Coactivator forges pathway for prostate cancer metastatic survival Feb 16, 2015 New finding could help define pathway to develop a drug against prostate cancer metastasis, according to researchers at Baylor.